Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.33 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.33 |
| ▸ | KDM4A | O75164 | 1/20 | 0.33 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.33 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL360118 | 1.00 | KDM1A (0.38) | KDM1ABLMPTPN1KDM4CKDM4A | |
| SCHEMBL5580242 | 0.93 | KDM4C (0.41) | KDM1ABLMKDM4CKDM4APHF8 | |
| SCHEMBL1275062 | 0.93 | KDM4C (0.41) | KDM1ABLMKDM4CKDM4APHF8 | |
| SCHEMBL1274435 | 0.93 | KDM4C (0.41) | KDM1ABLMKDM4CKDM4APHF8 | |
| SCHEMBL5561689 | 0.89 | CA1 (0.39) | KDM1ACA1GRIK1KDM4ELMNA | |
| SCHEMBL5561691 | 0.89 | CA1 (0.39) | KDM1ACA1GRIK1KDM4ELMNA | |
| SCHEMBL905414 | 0.79 | CES1 (0.40) | PTPN1CA1 | |
| SCHEMBL147780 | 0.79 | CES1 (0.40) | PTPN1CA1 | |
| SCHEMBL147781 | 0.79 | CES1 (0.40) | PTPN1CA1 | |
| SCHEMBL273807 | 0.79 | KDM1A (0.43) | KDM1ABLMPTPN1KDM4CKDM4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 385 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3478822-B1 | PRESERVATION OF MICROORGANISMS | Yun NV (BE) | 2023-06-07 | — | — | EP | claimed |
| US-20220323368-A1 | ACTIVE SUBSTANCE DELIVERY SYSTEM WITH DELAYED DELIVERY | CAPNOPHARM GMBH (DE) | 2022-10-13 | — | — | US | claimed |
| US-20220241213-A1 | DELAYED AND SUSTAINED DELIVERY OF ANTICANCER DRUGS | CAPNOPHARM GMBH (DE) | 2022-08-04 | — | — | US | claimed |
| EP-3982918-A1 | DELAYED AND SUSTAINED DELIVERY OF ANTICANCER DRUGS | CAPNOMED GmbH (DE) | 2022-04-20 | — | — | EP | claimed |
| US-10588944-B2 | Methods and compositions for managing reproduction | Ostara Biomedical Ltd. (GB) | 2020-03-17 | — | — | US | claimed |
| US-20190321302-A1 | PRESERVATION OF MICROORGANISMS | Yun NV (BE) | 2019-10-24 | — | — | US | claimed |
| CN-109952368-A | The preservation of microorganism | YUN股份有限公司 | 2019-06-28 | — | — | CN | claimed |
| EP-3478822-A1 | PRESERVATION OF MICROORGANISMS | YUN NV (BE) | 2019-05-08 | — | — | EP | claimed |
| WO-2018002248-A1 | PRESERVATION OF MICROORGANISMS | Yun NV (BE) | 2018-01-04 | — | — | WO | claimed |
| US-20170333341-A1 | NANOPARTICLES LOADED WITH CHEMOTHERAPEUTIC ANTITUMORAL DRUG | BIOALLIANCE PHARMA SA (FR) | 2017-11-23 | — | — | US | claimed |
| US-8062669-B2 | Vectorization system comprising nanoparticles of homogenous size of at least one polymer and at least one positively charged polysaccharide and method for the preparation thereof | BIOALLIANCE PHARMA (FR) | 2011-11-22 | — | — | US | claimed |
| EP-1513506-B1 | TARGETING SYSTEM COMPRISING UNIFORMLY-SIZED NANOPARTICLES WITH AT LEAST ONE POLYMER AND AT LEAST ONE POSITIVELY-CHARGED POLYSACCHARIDE AND PREPARATION METHOD THEREOF | BIOALLIANCE PHARMA (FR) | 2011-10-19 | — | — | EP | claimed |
| US-20060134220-A1 | Vectorization system comprising nanoparticles of homogenous size of at least one polymer and at least one positively charged polysaccharide and method for the preparation thereof | BIOALLIANCE PHARMA (FR) | 2006-06-22 | — | — | US | claimed |
| EP-1513506-A1 | TARGETING SYSTEM COMPRISING UNIFORMLY-SIZED NANOPARTICLES WITH AT LEAST ONE POLYMER AND AT LEAST ONE POSITIVELY-CHARGED POLYSACCHARIDE AND PREPARATION METHOD THEREOF | Bioalliance Pharma (S.A.) (FR) | 2005-03-16 | — | — | EP | claimed |
| EP-0820300-B1 | CONTROLLED RELEASE BIODEGRADABLE NANOPARTICLES CONTAINING INSULIN | ELAN CORP PLC (IE) | 2004-03-10 | — | — | EP | claimed |
| WO-2004000287-A1 | TARGETING SYSTEM COMPRISING UNIFORMLY-SIZED NANOPARTICLES WITH AT LEAST ONE POLYMER AND AT LEAST ONE POSITIVELY-CHARGED POLYSACCHARIDE AND PREPARATION METHOD THEREOF | BIOALLIANCE PHARMA (FR) | 2003-12-31 | — | — | WO | claimed |
| EP-0820300-A1 | CONTROLLED RELEASE BIODEGRADABLE NANOPARTICLES CONTAINING INSULIN | ELAN CORPORATION PLC (IE) | 1998-01-28 | — | — | EP | claimed |
| US-5641515-A | COMPLEX OF INSULIN AND POLYALKYLCYANOACRYLATE OR FREE-INSULIN LOADED POLYALKYLCYANOACRYLATE | ELAN CORPORATION, PLC (IE) | 1997-06-24 | — | — | US | claimed |
| WO-1996031231-A1 | CONTROLLED RELEASE BIODEGRADABLE NANOPARTICLES CONTAINING INSULIN | ELAN CORPORATION, PLC (IE) | 1996-10-10 | — | — | WO | claimed |
| WO-1996018635-A1 | FULLERENE-OLIGONUCLEOTIDE OR FULLERENE-NUCLEOTIDE CONJUGATES, COMPLEXES THEREOF WITH NANOPARTICLES, AND THERAPEUTICAL USES THEREOF | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 1996-06-20 | — | — | WO | claimed |